Hideki Kitahara, MD

Original Contribution

Damage to Polymer of Undelivered Sirolimus-Eluting Stents

08/01/2008

Hideki Kitahara , MD;

Yoshio Kobayashi , MD;

Masashi Yamaguchi , PhD;

Yoshihide Fujimoto , MD;

Mizuo Nameki , MD;

Takashi Nakayama , MD;

Nakabumi Kuroda , MD;

Alssei Komuro , MD;

A sirolimus-eluting stent (SES) consists of 3 components: 1) metallic stent; 2) sirolimus as an antiproliferative agent to inhibit neointimal formation; and 3) a polymer coating used as a drug-carrier vehicle (Figure 1).1 Polymer also plays...

A sirolimus-eluting stent (SES)...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Mechanism of Edge Restenosis After Sirolimus-Eluting Stent Implantation

01/30/2012

Hideki Kitahara , MD;

Yoshio Kobayashi , MD;

Yoshihide Fujimoto , MD;

Eiji Ichimoto , MD;

Kenichirou Kubo , MD;

Tomoaki Miyayama , MD;

Yo Iwata , MD;

Abstract: Objectives. The present study evaluated the mechanism of edge restenosis after sirolimus-eluting stent (SES) implantation using serial (post-intervention and follow-up) intravascular ultrasound (IVUS) analysis. Background. There is...

Abstract: Objectives. The...

01/30/2012

Journal of Invasive Cardiology